These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35765655)

  • 21. Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.
    Lin KJ; Wang TJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Chuang JH; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
    Ji Q
    Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.
    Victorino DB; Nejm M; Guimarães-Marques M; Scorza FA; Scorza CA
    Pharmaceut Med; 2021 Jan; 35(1):11-19. PubMed ID: 33409802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales.
    Dahlén AD; Dashi G; Maslov I; Attwood MM; Jonsson J; Trukhan V; Schiöth HB
    Front Pharmacol; 2021; 12():807548. PubMed ID: 35126141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH
    Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of genital and urinary tract infections associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea.
    Yang H; Choi E; Park E; Na E; Chung SY; Kim B; Han SY
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00910. PubMed ID: 35005849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.
    Garry EM; Schneeweiss S; Eapen S; Petruski-Ivleva N; Cheever E; Murk W; Rajan A; Rassen JA; Gambino D; Jang H; Rubin E; Jan S
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1442-1452. PubMed ID: 31778623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Luo Y; Lu K; Liu G; Wang J; Laurent I; Zhou X
    Clin Drug Investig; 2018 Dec; 38(12):1089-1108. PubMed ID: 30255388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2.
    Yandrapalli S; Malik A; Horblitt A; Pemmasani G; Aronow WS; Frishman WH
    Cardiol Rev; 2020; 28(5):219-235. PubMed ID: 32271194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.
    Scheen AJ
    Circ Res; 2018 May; 122(10):1439-1459. PubMed ID: 29748368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence.
    Pozo L; Bello F; Suarez A; Ochoa-Martinez FE; Mendez Y; Chang CH; Surani S
    World J Diabetes; 2019 May; 10(5):291-303. PubMed ID: 31139316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug repurposing for Alzheimer's disease:
    Kumar N; Gahlawat A; Kumar RN; Singh YP; Modi G; Garg P
    J Biomol Struct Dyn; 2022 Apr; 40(7):2878-2892. PubMed ID: 33170091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis.
    Yang S; He W; Zhao L; Mi Y
    PLoS One; 2022; 17(4):e0267025. PubMed ID: 35421174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery.
    Lee J; Noh S; Lim S; Kim B
    Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33435282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus.
    Davidson MH
    Postgrad Med; 2014 May; 126(3):56-65. PubMed ID: 24918792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel antidiabetic drugs in diabetic kidney disease accompanying type 2 diabetes - a minireview.
    Wieczorek-Surdacka E; Surdacki A; Świerszcz J; Chyrchel B
    Folia Med Cracov; 2020; 60(4):97-101. PubMed ID: 33821854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
    Li Y; Rosenblit PD
    Curr Cardiol Rep; 2018 Sep; 20(11):113. PubMed ID: 30259238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus.
    Lee S; Jeon S; Kim HS
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):195-207. PubMed ID: 35413782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.